Publication | Closed Access

Pre-therapeutic dosimetry of normal organs and tissues of 177Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer

Normal OrgansUrologyOncologyGenitourinary CancerMedicinePharmacotherapyCastration-resistant Prostate CancerCancer TreatmentProstatic DiseasePharmacologyPre-therapeutic Dosimetry